Report Overview

Global Head and Neck Cancer Therapeutics Market - Industry Trends & Forecast Report 2028

Global Head and Neck Cancer Therapeutics Market was worth USD 1.1 billion in 2021 and is further projected to reach USD 2.6 billion by the year 2028, exhibiting a CAGR of 12.6% during the forecast period (2022-2028). The rapid expansion of the market is predominantly due to the continuous progress made in the healthcare business, particularly in the therapeutics sector for cancer treatments, which is largely responsible for the market's rapid expansion. The Global Head and Neck Cancer Therapeutics Market is expected to expand in future years on account of the rising incidence of cancers such as head cancer and throat cancer. The development of the pharmaceutical sector is also expected to contribute to the market's expansion.

Head and Neck Cancer Therapeutics - Overview

Head and neck cancers include oral, pharynx, larynx, nasal, paranasal, thyroid, and salivary gland tumors. Head and neck cancer begins with the squamous cells lining the mucosal surfaces. Head and neck cancers are defined by their origin. Multidisciplinary teams care for head and neck cancer patients. Before treatment, each doctor evaluates the scans. Increased usage of tobacco and tobacco-based products, smoking, and alcohol consumption is leading to a rise in throat cancer incidence, which will drive the Global Head and Neck Cancer Therapeutics Market in the next five years.

Global Head and Neck Cancer Therapeutics Market Forecast and Trends

Growth Drivers

Rising Biosimilar Use

A biosimilar called a follow-on biologic or a subsequent entry biologic, is a biologic medical product nearly identical to the original medicine but made by a new business. This approach relies on medications that have already undergone the costly process of research and development, and as a result, they may be cheaper to produce and test than the reference biologic pharmaceuticals. Thus, the biosimilar can provide patients with cost-effective therapy options at reduced cost.

Rise in early diagnostic methods giving a boon to the market

Forecasts for upcoming years indicate that diagnostic methods will occupy the greatest revenue shares of the market due to rising demand for early and accurate diagnosis of cancer patients. Thus, the Global Head and Neck Cancer Therapeutics Market is expected to expand due to rising demand for early cancer detection, as a treatment for early-stage cancer is relatively easy and has a greater success rate.

Restraints

Frequent failure at the end of the process, Substantial medication adverse effects are a fact of life.

The maintenance of functionality is equally important as the secure removal of the malignancy. The proximity of functionally important anatomical elements makes functional restoration a challenging problem that calls for a multidisciplinary strategy. Multimodal treatment improves survival rates in advanced cancers but is associated with more treatment-related side effects.

Impact of COVID-19 on Global Head and Neck Cancer Therapeutics Market

The pandemic of coronavirus disease 2019 (COVID-19), which was caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), presents a challenge to the world's healthcare system that has never been seen before. This challenge includes the provision of standard care to patients who have cancer. During this time, virtually all in-hospital treatments for cancer patients were halted, and radiation therapy was only administered to certain individuals with the intention of curing them in accordance with stringent protocols for patient protection.

Global Head and Neck Cancer Therapeutics Market - By Type

The global market for head and neck cancer treatments can be segmented either by diagnostic method or by therapy, depending on the type of cancer being treated. As the most common method of treatment for head and neck cancer, surgery is anticipated to hold the top spot in the global market for head and neck cancer therapies during the course of the forecast period. Radiation therapy is a method that can be utilized to reduce the risk of cancer returning, and it is anticipated that it will contribute the second highest share to the global market for head and neck cancer therapeutics. In the treatment of head and neck cancer, chemotherapy is typically administered in conjunction with other treatments, and as a result, the market share it commands is quite small.

Global Head and Neck Cancer Therapeutics Market - By Treatment Type

On the basis of the disease indication, Global Market for Head and Neck Cancer Therapeutics has been divided into the following categories: laryngeal cancer, cancer of the lip and oral cavity, nasopharyngeal cancer, oropharyngeal cancer, salivary gland cancer, hypopharyngeal cancer and other types of head and neck cancer. Because cancer has such a high prevalence all over the world, the lip and oral cavity cancer indication type segment is anticipated to contribute the largest contribution to the global market for head and neck cancer treatments.

Global Head and Neck Cancer Therapeutics Market - By Route of Administration

Based on the Route of Administration, the Global Head and Neck Cancer Therapeutics Market is segmented into injectable and oral. Among the two, injectables dominate the market with their ease of administration. Injectable drugs are mixed in the sterile diluent to form a solution that can be quickly injected into the body. This is due to elements including the widespread accessibility of many HNC therapeutic medications in injectable form, improved accessibility, and high efficacy of injectable treatments. Injectable forms of several medications are readily accessible. For instance, patients with head and neck cancer get an intravenous infusion of the Merck & Co., Inc. drug Keytruda.

Global Head and Neck Cancer Therapeutics Market - By Region

The market can be classified into North America, Asia Pacific, Europe, Middle East & Africa, and Latin America. In 2021, North America dominated the world market for head and neck cancer. The American Cancer Society estimates that 4% of all cancer cases in the US are head and neck cancer. Around 48,740 men and 17,890 women are anticipated to be diagnosed with head and neck cancer in 2021. According to estimates, head and neck cancer will cause 14,620 deaths in the United States in 2021. As a result, the market for head and neck cancer medications in North America is expanding due to the increased incidence of head and neck cancer. Therefore, the rising prevalence of head and neck cancer is driving the growth of the head and neck cancer therapeutics market in North America.

Competitive Landscape

• Pfizer Inc., Eli Lilly, and Company, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Ltd., GlaxoSmithKline PLC, Novartis International AG, Sanofi, Bayer AG, Hoffmann-LA Roche AG, Merck & co., INC., AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., and Other Prominent Players are some of the companies that are active in this industry. It is anticipated that the approval of Imfinzi and Bavencio will generate a significant market opportunity for AstraZeneca and Pfizer, respectively, throughout the duration of the forecast period.

• Several corporations, most notably Sanofi and Eli Lilly, have been impacted as a result of patents that have expired and increased competition from biosimilar drugs. It is anticipated that a number of market participants would collaborate on fulfilling unmet market needs, the discovery of new targets, and developing more robust therapeutic pipelines.

Scope of the Report

By Type

• Diagnostic Method

  1. Biopsy

  2. Imaging

  3. Endoscopy

  4. Others

• Treatment

  1. Surgery

  2. Radiation Therapy

  3. Chemotherapy

  4. Immunotherapy

  5. Targeted Therapy

By Treatment Type

• By Disease Indication

• Lip And Oral Cavity Cancer

• Laryngeal Cancer

• Oropharyngeal Cancer

• Salivary Gland Cancer

• Nasopharyngeal Cancer

• Hypopharyngeal Cancer

By Route of Administration

• Injectable

• Oral

By End-User

• Hospitals

• Specialty Clinics

• Ambulatory Surgical Centers

• Others

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3. Global Head and Neck Cancer Therapeutics Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
         1. Rising Biosimilar Use
         2. Rise in early Diagnostic Methods
         3. Positive Healthcare Reforms
      2. Restraints
         1. Frequent failure at the end of the process, Substantial medication adverse effects are a fact of life
         2. Others
      3. Opportunities
         1. Increased demand for a combination treatment for head and neck cancer care
         2. Others
      4. Challenges
         1. High Treatment Cost
         2. Others
   3. Technological Advancement/Recent Development
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. Global Head and Neck Cancer Therapeutics Market Overview
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
         1. Diagnostic Method
            1. Biopsy
            2. Imaging
            3. Endoscopy
            4. Others
         2. Treatment
            1. Surgery
            2. Radiation Therapy
            3. Chemotherapy
            4. Immunotherapy
            5. Targeted Therapy
      2. By Treatment Type
         1. By Disease Indication
            1. Lip and Oral Cavity Cancer
            2. Laryngeal Cancer
            3. Oropharyngeal Cancer
            4. Salivary Gland Cancer
            5. Nasopharyngeal Cancer
            6. Hypopharyngeal Cancer
      3. By Route of Administration
         1. Injectable
         2. Oral
      4. By End-User
         1. Hospitals
         2. Specialty Clinics
         3. Ambulatory Surgical Centers
         4. Others
      5. By Region
         1. North America
         2. Europe
         3. The Asia Pacific
         4. Latin America
         5. The Middle East and Africa
5. North America Head and Neck Cancer Therapeutics Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Treatment Type
      3. By Route of Administration
      4. By End-User
      5. By Country
         1. United Type
         2. Canada
6. Europe Head and Neck Cancer Therapeutics Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Treatment Type
      3. By Route of Administration
      4. By End-User
      5. By Country
         1. Germany
         2. United Kingdom
         3. Italy
         4. France
         5. Spain
         6. Rest of Europe
7. The Asia Pacific Head and Neck Cancer Therapeutics Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Treatment Type
      3. By Route of Administration
      4. By End-User
      5. By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Australia
         6. Indonesia
         7. Singapore
         8. Malaysia
         9. Rest of Asia Pacific
8. Latin America Head and Neck Cancer Therapeutics Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Treatment Type
      3. By Route of Administration
      4. By End-User
      5. By Country
         1. Brazil
         2. Mexico
         3. Argentina
         4. Rest of Latin America
9. The Middle East & Africa Head and Neck Cancer Therapeutics Market
   1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Treatment Type
      3. By Route of Administration
      4. By End-User
      5. By Country
         1. Saudi Arabia
         2. UAE
         3. South Africa
         4. Iran
         5. Nigeria
         6. Egypt
         7. Turkey
         8. Rest of Middle East & Africa
10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Head and Neck Cancer Therapeutics Market
12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, SWOT, and Strategic Outlook) **
    1. Pfizer INC
    2. Eli Lilly and Company
    3. Sun Pharmaceutical Industries Limited
    4. Intas Pharmaceuticals Ltd
    5. Glaxosmithkline PLC
    6. Novartis International AG
    7. Sanofi
    8. Bayer AG
    9. Hoffmann-LA Roche AG
    10. Merck & co., INC
    11. Astrazenica PLC
    12. Teva Pharmaceutical Industries Ltd.
    13. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
    1. Qualitative Research
       1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
       1. Secondary Research
       2. Primary Research
    4. Breakdown of Primary Research Respondents
    5. Assumptions & Limitations

Note: Financial in information in case of non-listed companies will be provided as per availability

The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figures

Figure 1: Global Head and Neck Cancer Therapeutics Market Segmentation

Figure 2: Global Head and Neck Cancer Therapeutics Market Industry Value Chain Analysis

Figure 3: Global Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028

Figure 4: Global Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028

Figure 5: Global Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028

Figure 6: Global Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028

Figure 7: Global Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028

Figure 8: Global Head and Neck Cancer Therapeutics Market Share (%), By Region, By Value, 2018-2028

Figure 9: North America Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028

Figure 10: North America Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028

Figure 11: North America Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028

Figure 12: North America Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028

Figure 13: North America Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028

Figure 14: North America Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028    

Figure 15: Europe Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028

Figure 16: Europe Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028

Figure 17: Europe Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028

Figure 18: Europe Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028

Figure 19: Europe Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028

Figure 20: Europe Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028

Figure 21: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028

Figure 22: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028

Figure 23: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028

Figure 24: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028 

Figure 25: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028 

Figure 26: The Asia-Pacific Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028

Figure 27: Latin America Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028

Figure 28: Latin America Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028

Figure 29: Latin America Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028

Figure 30: Latin America Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028

Figure 31: Latin America Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028

Figure 32: Latin America Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028

Figure 33: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Value (USD Million), 2018-2028

Figure 34: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By Type, By Value, 2018-2028

Figure 35: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By Treatment Type, By Value, 2018-2028

Figure 36: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By Route of Administration, By Value, 2018-2028

Figure 37: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By End-User, By Value, 2018-2028

Figure 38: The Middle East & Africa Head and Neck Cancer Therapeutics Market Share (%), By Country, By Value, 2018-2028

Figure 39: Global Head and Neck Cancer Therapeutics Market Share Analysis, 2021

List of Tables

Table 1: Global Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), 2018-2028

Table 2: Global Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), 2018-2028

Table 3: Global Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 4: Global Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), 2018-2028

Table 5: Global Head and Neck Cancer Therapeutics Market Size. By Region, By Value (USD Million), 2018-2028

Table 6: North America Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), 2018-2028

Table 7: North America Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), 2018-2028

Table 8: North America Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 9: North America Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), 2018-2028

Table 10: North America Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028 

Table 11: Europe Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), By Value 2018-2028

Table 12: Europe Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), By Value 2018-2028

Table 13: Europe Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), By Value 2018-2028

Table 14: Europe Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), By Value 2018-2028

Table 15: 40 Europe Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028

Table 16: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), By Value 2018-2028

Table 17: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By Type, By Value 2018-2028

Table 18: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By Treatment Type, By Value 2018-2028

Table 19: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By Route of Administration, By Value 2018-2028

Table 20: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By End-User, By Value 2018-2028

Table 21: The Asia-Pacific Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028

Table 22: Latin America Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), By Value 2018-2028

Table 23: Latin America Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), 2018-2028

Table 24: Latin America Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 25: Latin America Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), 2018-2028

Table 26: Latin America Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028  

Table 27: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Type, By Value (USD Million), 2018-2028

Table 28: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Treatment Type, By Value (USD Million), 2018-2028

Table 29: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By Route of Administration, By Value (USD Million), 2018-2028

Table 30: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size, By End-User, By Value (USD Million), 2018-2028

Table 31: The Middle East & Africa Head and Neck Cancer Therapeutics Market Size (USD Million), By Country, By Value 2018-2028 

Table 32:  List of Key Players and Their Offerings

Table 33:  Competitive Benchmarking, by Operating Parameters

Table 34        Pfizer INC Company Overview

Table 35        Pfizer INC Financial Overview

Table 36        Lilly Company Overview

Table 37        Lilly Financial Overview

Table 38        Sun Pharmaceutical Industries Limited Company Overview

Table 39        Sun Pharmaceutical Industries Limited Financial Overview

Table 40        Intas Pharmaceuticals Ltd Company Overview

Table 41        Intas Pharmaceuticals Ltd Financial Overview

Table 42        Glaxosmithkline PLC Company Overview

Table 43        Glaxosmithkline PLC Financial Overview

Table 44        Novartis International AG Company Overview

Table 45        Novartis International Financial Overview

Table 46        Sanofi Company Overview

Table 47        Sanofi Financial Overview

Table 48        Bayer AG Company Overview

Table 49        Bayer AG Financial Overview

Table 50        Hoffmann –LA Roche AG Company Overview

Table 51        Hoffmann –LA Roche AG Financial Overview

Table 52        Merck & Co., INC Company Overview

Table 53        Merck & Co., INC Financial Overview

Table 54        Astrazenica PLC Company Overview

Table 55        Astrazenica PLC Financial Overview

Table 56        Teva Pharmaceutical Industries LTD Company Overview

Table 57        Teva Pharmaceutical Industries LTD Financial Overview